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Abstract 
 
Therapist adherence has been shown to contribute to the effectiveness of treatment interventions. The role in a 
patient’s decision to drop out of treatment, however, is unknown. This study investigates whether therapist 
adherence affects clinical outcome and the risk for dropout. Patients diagnosed with panic disorder with 
agoraphobia (N = 265) were treated in one of two CBT variations: with (T+) and without (T-) explicit 
therapist-guided exposure. Significant associations between lower levels of adherence and symptomatic 
improvement were observed in treatment completers in the T- condition and dropouts in T+ condition suggesting 
that adherence-outcome relations are potentially contributed by patient and treatment characteristics. Moreover, 
our results propose that patient related difficulties with exposure procedures may lead to lower adherence and 
dropout.  
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Therapist adherence to a treatment manual influences outcome and dropout rates: 
Results from a multicenter randomized clinical CBT trial for panic disorder with 
agoraphobia  
1. Introduction 
Therapist compliance with an intended intervention is a prerequisite for understanding the mechanisms of 
action in psychotherapy treatment (Perepletchikova & Kazdin, 2005). Manual-based interventions facilitate the 
comparison of therapies on potentially confounding unspecific parameters (Heimberg & Becker, 1994) and 
ensure tailored treatment elements to optimize the mechanisms of change (Luborsky & DeRubeis, 1984). In spite 
of that, the advantages of manualized treatment implementation might not apply unrestrictedly for the 
association to treatment outcome. Theoretically, high levels of therapist adherence should be associated with 
better outcomes if relevant treatment elements are delivered as intended (e.g., Emmelkamp, Bouman, & Blaauw, 
1994; Schulte, Künzel, Pepping, & Schulte-Bahrenberg, 1992). Empirically studies showed, however, that high 
adherence to a manual is negatively associated with symptomatic improvement (e.g., DeRubeis & Feeley, 1990, 
in CBT for depression; Huey, Henggeler, Brondino, & Pickrel, 2000, in multisystemic therapy for delinquent 
behavior). Research of Barber et al. (2006, in individual drug counseling) and Hogue et al. (2008, in CBT and 
multidimensional family therapy for adolescent substance use) suggest even curvilinear relationships between 
adherence and outcome. The disagreement on the role of adherence in the treatment process might be based on 
the fact that prior studies failed to examine patients who discontinued treatment. This is problematic because 
potential differences between completers and dropouts could bias estimates of complete samples. 
Analyzing the overall sample might be especially important when implementing exposure-based CBT, a 
treatment that needs to be adapted to patients who have difficulty fully engaging in this effortful treatment. To 
our knowledge, only White et al. (2010) investigated the association between treatment factors and dropout in 
CBT for patients with panic disorder with agoraphobia (PD/AG) suggesting that adherence did not predict 
treatment complementation. Based on clinical considerations, the importance of therapist adherence might 
potentially differ across treatment elements and individual patient requirements (Perepletchikova & Kazdin, 
2005). A high anxious patient, for instance, with strong avoidance behavior and thoughts of dropping out might 
require more time for exposures than intended in the treatment manual. In this case, it is comprehensible that the 
therapist adheres differently to a manual compared to a therapist treating a patient who will definitely complete 
the treatment. The optimal level of adherence in exposure treatment manuals may also vary as a function of the 
reasons for dropout and the timing of the dropout. Patients who are afraid or not motivated enough for exposure 
in situ might drop out at time points or due to reasons which are related to exposure exercises. Consequently, the 
level of therapist adherence before and during exposure elements seems to be an important factor for treatment 
outcome. Keeping these points in mind, it is highly recommended to examine the association of adherence and 
outcome in the entire patient cohort including completers and dropouts. 
The lack of strong and consistent findings in the literature may also result from therapist characteristics that 
influence the degree of adherence (Smith, Daunic, & Taylor, 2007; Webb et al., 2010) such as therapist 
competence and experience (Lambert & Bergin, 1994; Perepletchikova & Kazdin, 2005). Competence refers to 
the quality of treatment implementation and reflects the skills of the therapist such as the appropriate adaption of 
interventions and procedures, the style of communication and the ability for clinical reasoning (Perepletchikova 
& Kazdin, 2005). A very low level of competence is assumed to not influence treatment outcome if a therapist is 
adherent enough to the protocol, whereas a medium to high level of competence might affect the relation 
between lower levels of adherence and outcome (Barber et al., 2006, CBT in 95 cocaine-dependent outpatients). 
Therapist experience was found to be associated with competence and refers to the amount of theoretical and 
practical knowledge of a therapist according to a special treatment or patient group (Siqueland et al., 2000). 
Contrary to common belief, therapists with more experience tend to have lower levels of adherence than less 
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experienced therapists (Henry et al., 1993; Siqueland et al., 2000). Some authors explained this by stating that 
experienced therapists stick to their established ways of conducting therapy (Margison et al., 2000) and have 
more barriers learning new therapeutic strategies (Perepletchikova & Kazdin, 2005). Considering the potential 
influence of competence and experience might help to identify the core mechanisms of adherence to a CBT 
manual in symptomatic outcome in patients with PD/AG.  
In the present study, we examined the association between therapist adherence and both treatment outcome 
and dropout risk for patients with PD/AG treated with an exposure-based CBT. We hypothesized that adherence 
levels (1) differ between therapists who treated completers vs. those who treated dropouts, (2) are related to 
timing and reasons of dropouts, and (3) are related to treatment outcome. Furthermore, all these associations 
were examined with and without the influence of therapist competence and experience. 
2. Methods 
2.1 Trial design 
These data stem from a multicenter study for patients with PD/AG (n=369) randomized either to one of two 
conditions of CBT or to a waitlist control group which was excluded from the present analyses. The active 
treatment groups were based on a 12-session manualized treatment protocol (Lang, Helbig-Lang, Westphal, 
Gloster, & Wittchen, 2011) carried out over approximately 6 weeks, and followed by two booster sessions. The 
CBT was based on established manuals (Craske & Barlow, 2007) which were previously evaluated as effective 
for patients with PD/AG in several clinical trials (Barlow, Gorman, Shear & Woods (2000) and developments in 
exposure-based CBT (Baker-Morrissette, Spiegel, & Heinrichs, 2005; Richard, Lauterbach, & Gloster, 2007). 
The study manual consisted of psychoeducation, behavioral analysis of the patients’ symptoms and associated 
coping behaviors, rationale for exposure (i.e., sufficiently long and repeated exposure to feared stimuli without 
utilization of safety behaviors leads to fear reduction), interoceptive exposure, standardized in situ exposure (i.e., 
bus, shopping mall, and forest), anticipatory anxiety, individualized in situ exposure (i.e., of the patients’ most 
feared situations), and relapse prevention. In situ exposures were either accompanied by the therapist (T+) or 
thoroughly planned including mental rehearsal, anticipation of problems and with identical instructions not to 
use safety behaviors in the therapy room (T-). Methods and design of the study have been described in greater 
detail elsewhere (Gloster et al., 2009). 
2.2 Therapists 
Therapists (N=58) were advanced-level clinical psychology graduate students and post-docs experienced in 
CBT of anxiety disorders. During a three-day intensive training workshop, therapists were trained to follow the 
manual specifications and required to pass a certification process consisting of recorded role-plays scored by 
experts. During treatment, all therapists were involved in weekly manual-specific supervision.  
2.3 Patients  
The present study comprises N = 265 patients whose took part in the active treatment of the overall outcome 
study (Gloster et al., 2009, 2011). Patients were recruited from ongoing clinical care, physician referral and via 
additional advertisements in various media outlets across eight study centers. Eligible for inclusion were those 
who met DSM-IV-TR (Association, 2000) diagnostic criteria for PD/AG as validated by a standardized 
computer-administered personal Composite International Diagnostic Interview (CAPI-WHO-CIDI; DIAX-CIDI 
version, Wittchen, & Pfister, 1997); a clinical interview score ≥ 18 on the Structured Interview Guide for the 
Hamilton Anxiety Scale (SIGH-A; Shear et al., 2001) in Anxiety and Depression, a score ≥ 4 on the Clinical 
Global Impressions (CGI; Guy, 1976) Scale, and aged between 18 to 65. Patients were excluded if they reported 
clinically significant suicidal intent, not comply with the study requirements, met diagnostic criteria for any 
Psychotic or Bipolar Disorder, Borderline Personality Disorder, current Alcohol Dependence or had a medical 
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condition that could explain the patient’s symptoms. Other current comorbid diagnoses were allowed unless they 
were of primary clinical concern of the treating institution. Patients had to agree cease taking 
psychopharmacological medication or have concomitant other psychotherapy. Support and therapy was provided 
for patients who were excluded as well as those previously in the wait list condition.  
2.4 Definition of completers and dropouts 
Treatment completion was defined as finishing the first 12 sessions irrespective of the two booster sessions 
(n = 220; 119 T+; 101 T-). Dropout was defined as terminating the treatment before session 12 without the 
therapist's endorsement (n = 45; 24 T+; 21 T-). Dropouts after baseline assessment but prior to the first session 
were excluded from analyses because of the absence of recorded therapy sessions. The definition of dropouts 
differs from the overall outcome study (Gloster et al., 2011) but is consistent with previous theoretical 
recommendations for studies targeting dropouts (e.g., Reis & Brown, 1999; Wierzbicki & Pekarik, 1993). 
Completers and dropouts did not differ in their socio-demographic and clinical characteristics (Table 1).  
Across treatment conditions, patients were grouped by timing and reasons of dropout. Because exposure was 
considered as a core element in our study timing of dropout was split into early (not focusing exposure in situ; 
session 1-4; n = 7, 15.6%), intermediate (decision for exposure in situ; session 5-6; n = 15, 33.3%), and late 
(conducting and discussing exposure in situ; session 7-12; n = 23, 51.1%) dropout. Reasons for dropout were 
specified prior to the study and documented by the therapist. Patients were divided into those who dropped out 
due to exposure-related reasons such as too anxious (n = 6, 13.3%) or not motivated enough for exposure (n = 6, 
13.3%) vs. reasons related to other issues such as organizational problems (n = 8, 17.8%), interrupted contact (n 
= 8, 17.8%), symptom improvement (n = 4, 8.9%), symptom deterioration (n = 2, 4.4%), more relevance of other 
disorders (n= 1, 2.2%), and other reasons (n = 10, 22.2%), e.g. somatic disease or problems with family and 
relationship. 
2.5 Rating procedure of therapist adherence 
All treatment sessions were videotaped except those portions of the therapy that occurred outside the 
therapy room (i.e., in situ exposure). Nevertheless, the parts of these sessions that occurred in the room prior to 
leaving (preparation) and returning (evaluation) were recorded. Approximately 20% of all sessions were 
randomly selected stratified by treatment session (N = 760, 19.3%) with twofold probability for sessions 5 and 6 
in which the treatment rational was implemented and the decision for conducting exposures was made. In the 
present study sessions between baseline to post (session 1 to 12, n= 689) were used. Due to the random selection 
of treatment sessions, for each patient a different number of videos were analyzed. Replacement of therapist for 
single sessions was necessary when therapists were sick or absent for other important reasons in order to ensure 
continuity of the treatment. Videotapes of these sessions were excluded from analyses (n=17). All selected 
sessions were rated by 15 trained students of clinical psychology for the degree of adherence. The training 
process was supervised by three experts in the CBT manual, and was realized in a two-day workshop of 
self-rating treatment sessions and discussing discrepancies between trainee and experts’ ratings. After the 
training assessors were required to independently rate three certification videos, each of which had to be rated 
within one point of the average experts ratings on each item.  
2.6 Assessment 
Therapist adherence was operationally defined as the degree to what the therapist adhered to the manual 
meaning that explanations and exercises were instructed as prescribed in the treatment protocol, and measured 
using the Therapist Adherence and Competency Rating Scales (TACRS; Gloster, Einsle, Lang, Hauke, & 
Wittchen, 2008). The TACRS comprises checklists including all active ingredients to be implemented in a 
session such as psycho-education, functional analysis, goal setting, interoceptive exposure, thought experiment, 
exposure in situ, motivational procedures and relapse prevention. All ingredients were reviewed via a 9-point 
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Likert-type scale from 0 (nonexistent adherence) to 8 (high adherence). Based on the scores of the ingredients 
raters assessed the total degree of adherence ranging also from 0 (nonexistent adherence) to 8 (high adherence). 
Therapist adherence ratings in the present study were distributed as follows: 2.8% of sessions were scored with 0 
to 2 points, 16.3% with 3 to 4 points, 58.5% with 5 to 6 points, and 22.3% with 7 to 8 points.  
Table 1 
Socio-demographic and clinical characteristics of patients and therapists 
  
Total sample 
 (N = 265) 
 
Completers  
(n = 220) 
 
Dropouts 
(n= 45) 
  
Variable N %  N %  N %  p* 
Patients characteristics           
  Age, years 35.1 (10.5)  34.9 (10.6)  36.18  .461 
  Female 193       72.8  160         72.7  33         .934 
  Living status           
.763 
 With parents 15 5.7  13 5.9  2 4.4  
 With partner  182 68.7  153 69.6  29 64.4  
 Alone 51 19.3  41 18.6  10 22.2  
 Others  17 6.4  13 5.9  4 8.9  
  Years of education          
.117 
 8 29 10.9  21 9.6  8 17.8  
 10 120 45.3  98 44.6  22 48.9  
 12-13+ 109 41.1  96 43.6  13 28.9  
 no formal degree 7 2.6  5 2.3  2 4.4  
  Employ status          
.217 
 University Student 9 3.4  2 3.2  2 4.4  
 Job training 72 27.2  58 26.4  14 31.1  
 Employed 153 57.8  125 56.8  28 62.2  
 Unemployed 29 10.9  28 12.7  1 2.2  
 Other 2 .8  2 .9  0 0  
  Social class          
.471 
 Lowest 14 5.4  12 5.5  2 4.8  
 Lower middle 59 22.8  48 22.1  11 26.2  
 Middle 155 59.9  128 58.9  27 64.3  
 Upper middle/ upper 31 11.8  29 13.4  2 4.8  
Attended number of sessions 6.87  (2.43) 
 
12 (0) 
 
6.87  
 .001 
       
 Adherencea 5.54 (1.26)  5.57 (1.24)  5.39  .154 
 Competencea 5.73 (1.24)  5.72 (1.26)  5.8  .484 
 Experience, years 2.93 (1.89)  3.92 (1.72)  3 (3.22)  .922 
Note. * Fisher's exact tests for categorical data; t-test analyses for continuous data, *significance of differences between completers and 
dropouts; aTherapist Adherence and Competence Rating scales (0-8). 
 
Therapist competence was operationally defined as the degree to what the therapist delivered the treatment 
in a competent way such as encouraging motivation, handling of questions, or dealing with difficult situations 
during the treatment. Based on a checklist including all active treatment elements raters assessed the total score 
of competence in the end of session on a 9-point Likert-type scale from 0 (inexistent competence) to 8 (high 
competence) using TACRS. In the present study therapist competence ratings were distributed as follows: 1.6% 
of sessions were scored with 0 to 2 points, 14.1% with 3 to 4 points, 55.6% with 5 to 6 points, and 28.7% with 7 
to 8 points. The TACRS were developed for this study and showed good to acceptable interrater reliability 
calculated by intraclass correlation (ICC) resulting in ICC = .72 for adherence and ICC = .62 for competence. 
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Prior correlation analyses revealed a significant relation between adherence and competence (r = .64, p < .001) 
indicating that higher levels of adherence were related to higher levels of competence. 
Therapist experience was operationally defined as the number of years of practicing since starting their 
post-graduate psychotherapy training (typically 3-5 years in Germany) and was measured using a questionnaire 
of professional therapist experience (Kuhbach, 2009). The experience of our therapists ranged from 0 to 9 years 
with an overall mean score of three years and was denoted as follows: n = 12 (21.8 %) with 0 to 1 year, n = 33 
(60 %) with 2 to 4 years, n = 9 (16.4%) with 5 to 6 years and n = 1 (1.8%) with 9 years. Correlations between 
experience and both adherence (r = .08, p = .055) and competence (r = .02, p = .6) were no significant. 
Primary outcome variables were assessed at baseline and post assessment and included the total scores of a) 
the SIGH-A (Shear et al., 2001), a 14-item questionnaire measuring the severity of anxiety symptoms rated by an 
assessor, b) the CGI (Guy, 1976) measuring symptom severity and therapeutic improvement ranging from 1 
(normal) to 7 (most severely ill) rated by an assessor, c) the Mobility Inventory (MI; Chambless, 1985), a 
self-reported questionnaire consisting of 27 specific situations without being accompanied by a trusted person 
which range from 1 (never avoid) to 5 (always avoid). The number of panic attacks was taken from the Panic- 
and Agoraphobia Scale (PAS; Bandelow, 1999) and rated on a five-point scale ranging from 0 (no attacks) to 4 
(over seven attacks). All outcome measures have good test-retest reliability, high internal consistencies, and 
reasonable concurrent validity (e.g., Bandelow et al., 1998; Leon et al., 1993; Shear et al., 2001). As expected 
due to LOCF, completers and dropouts differed significantly in all outcome measures with a greater 
improvement for completers of -10.38 (SE = 7.42) points in the SIGH-A, -1.11 (SE = .17) in the CGI, and -.62 
(SE = .13) in the MI. The number of panic attacks did not differ significantly across both groups (M = -.29; SE 
= .4). 
2.7 Statistical Analysis 
In a first step, differences in therapist adherence were analyzed across sessions of a) completers vs. dropouts 
and b) specific subgroups of dropouts using multinomial logistic regressions. These models were commonly 
used when the dependent variable has more than two categories or when two or more variables need to be 
considered such as adherence, competence and experience in the present study. In a second step, associations 
between therapist adherence and treatment outcomes were analyzed across sessions of a) the total cohort, b) 
completers and c) dropouts using outcome mixed-effects linear regression models (MELR; Rabe-Hesketh & 
Skrondal, 2005). MELR adequately deal with dependency of data resulting from nesting within higher levels, 
which is the case in the multicenter design of this study (Nezlek, 2001). The maximum likelihood estimator was 
used to estimate the random intercept and other model parameters. Difference scores were calculated between 
baseline and the last observation carried forward (LOCF) at post-treatment (numbers of missing data to post 
upon request). In a third step, the interaction term for adherence * difference between completers and dropouts in 
adherence was entered into MELR in order to examine whether these two groups differed in the association 
between adherence and outcome. Coefficients rendered from MELR can be interpreted in such a way that 
negative differences indicated symptomatic improvement. Differences between treatment conditions (T+ and T-) 
and effects of therapist competence and experience on adherence were only reported in case of relevance. Data in 
the present study were analyzed using STATA for Windows, Version 11 (Stata Cooperation, 2009). Analyses 
were adjusted for the baseline score of the respective outcome. Normality of the distribution of outcome 
variables was checked by Skewness-Kurtosis-Tests and kernel density plots. All tests were two-sided and p < .05 
was the criterion for statistical significance.  
3. Results 
3.1 Adherence across completers and dropouts 
Contrary to our hypothesis, completers and dropouts did not differ in therapist adherence (Table 1). Analyses 
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across timing of dropout resulted in no differences in adherence between early vs. middle (OR = 1.13; CI = .724, 
1.77; p = .584), early vs. late (OR = .95; CI = .65, 1.4; p = .809) and middle vs. late (OR = .84; CI = .67, 1.17; p 
= .302) dropouts. Analyses across reasons of dropout suggest that therapists of patients with exposure related 
reasons for dropout showed lower levels of adherence (OR = .76; CI = .57; 1.01; p = .056). This result was 
clearly significant after considering therapist competence (OR = .55; CI = .39, .8; p = .002) or experience (OR 
= .74; CI = .55, .98; p = .036). As point of reference, adherence levels were also lower than those shown in 
completers (OR = .75; CI = .59, .96; p = .021). 
 
Table 2 
Associations between Therapist Adherence and Treatment Outcome (n=265) 
Outcome 
Adherence  Adjusted for competence  Adjusted for experience 
β
a
 p-value 95% CI  βa p-value 95% CI  βa p-value 95% CI 
            
∆SIGH-Ab .31 .142 -.1 – .73  -.04 .892 -.58, .5  .23 .283 -.19 - .65 
∆CGIc .03 .283 -.03 - .09  -.02 .654 -.09, .06  .02 .423 - .04 - .09 
∆MId .04 .078 0 - .08  -.02 .58 -.07, .04  0 .662 - .02 - .07 
∆PAe 0 .915 -.1 - .09  -.12 .05 -.24, .0  0 .998 -1.0 – 1.0 
Note. Negative scores represent more improvement; scores controlled for baseline; AV = Treatment Outcome; UV = Adherence; 
aunstandardized regression coefficients; bHamilton Anxiety Scale; cClinical Global Impression; dMobility Inventory; eNumber of panic attacks 
scored by Panic- and Agoraphobia Scale. 
3.2 Association between adherence and outcome  
Linear regression analysis revealed no significant associations between adherence and treatment outcome 
(Table 2 & 3), which was unexpected. Therapists of completers and those of dropouts did not differ in 
adherence-outcome relationships (interaction level of adherence x group, Table 3). Analyses across treatment 
conditions, however, showed a significant association between adherence and outcome in completers: Higher 
levels of adherence were associated with poor outcome in T- (SIGH-A: β = .75; CI = .07, 1.43; p = .031; CGI: β 
= .13; CI = .05, .22; p = .002) but not in T+ (SIGH-A: β = .17, .27; CI =  -.37, .7; p = .543; CGI: β = 0; CI = 
-.09, .09; p = .976). In turn, higher levels of adherence in dropouts were associated with poorer outcome in T+ 
(MI: β = .11; CI = .01, .22; p = .036) but not in T- (MI: β = -09; CI =. -.25, .07; p = .258). Results were no longer 
significant after analyses were adjusted for therapist competence. Therapist experience did not influence these 
associations (details available upon request). 
 
Table 3 
Associations between Therapist Adherence and Treatment Outcome in Completers and Dropouts 
Outcome 
Completers (n=220)  Dropouts (n=45)  Groupa x Adherence (n=265) 
β
b
 p-value 95% CI  βb p-value 95% CI  βb p-value 95% CI 
            
∆SIGH-Ac .38 .075 -.04  -.81  .53 .209 -.3 - 1.35  -.17 .728 -1.12 - .78 
∆CGId .06 .06 0 - .13  -.02 .664 -.13 - .1  -.08 .263 -.21 - .06 
∆MIe .04 .086 0 - .08  .07 .158 -.03 - .16  .01 .835 -.08 - .11 
∆PAf 0 .899 -.1 - .1  -.02 .879 -.21 - .25  -.04 .761 -.27- .2 
Note. Negative scores represent more improvement; scores controlled for baseline; AV = Treatment Outcome; UV = Adherence; acompleter 
vs. dropout; bunstandardized regression coefficients; cHamilton Anxiety Scale; dClinical Global Impression; eMobility Inventory; fNumber of 
panic attacks scored by Panic- and Agoraphobia Scale. 
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4. Discussion 
4.1 Summary of results 
The present study examined the impact of therapist adherence to a treatment manual on outcome, 
completion of treatment, and dropout risk. Results indicated that in a thoroughly standardized randomized 
controlled trial therapist adherence was generally high with little variation. The variation that occurred was not 
related to symptomatic change, even if therapist competence or experience were taken into account. Significant 
associations between lower levels of adherence and symptomatic improvement were only found in particular 
constellations such as completers in T- and dropouts in T+. Moreover, analyses across subgroups of dropouts 
revealed significantly lower levels of therapist adherence in patients who dropped out due to exposure-related 
reasons if therapist competence or experience were considered. However, all these effects were small in terms of 
effects size.  
4.2 Adherence across completers and dropouts  
The comparable high levels of adherence in both therapists who treated completers and those who treated 
dropouts suggest that the treatment was implemented as intended in the overall sample. Neither the timing nor 
the reasons of dropout were associated with therapist adherence, at least at the high level of adherence as found 
in the present study. In order to strengthen the assumption that levels of adherence are independent of dropout 
characteristics it would be necessary to repeat this study by analysing each therapy session including videotapes 
of exposure session outside the therapy room.  
Our data suggest, however, that the relationship between adherence and reasons of dropout was influenced 
by therapist competence and experience. Our results showed that in patients who dropped out due to 
exposure-related reasons CBT was implemented with lower adherence to the manual than in patients who 
dropped out due to other reasons and in those who completed treatment. Interestingly, therapists of patients who 
dropped out of treatment due to issues surrounding the exposure itself showed lower levels of competence and 
higher levels of experience. The explanation for this involves practical implications. Problems in adherently 
implementing the treatment manual might be based on the presence of both patient and therapist characteristics 
(Perepletchikova & Kazdin, 2005). If a patient is overly anxious or insufficiently motivated to commence 
exposure, a therapist may deliberately choose to spend more time as intended for specific treatment elements. In 
this case, implementing a treatment more flexibly might not show high adherence, but maybe evidence of 
experience. However, it is important to note that the advantage of more experienced therapists in therapy of 
patients is still disputable (Beutler et. al, 2004; Stein & Lambert, 1984, 1995). To ensure that a therapist do not 
stick to an established way of conducting therapy because of several years of experience, it is very recommended 
to critically review the therapeutic procedure and to check the patient’s level of clinical functioning and therapy 
motivation. In therapeutic practice a constantly debriefing of recorded therapy sessions in supervision might be 
helpful. 
4.3 Association between adherence and outcome in completers and dropouts 
In the overall sample, adherence to an exposure-based CBT manual was neither related to treatment 
outcome in patients who completed treatment nor in those who dropped out. These non-significant associations 
between adherence and outcome are consistent to several prior studies (e.g. Carroll, Nich & Rounsaville, 1997; 
Feeley, DeRubeis, & Gelfand, 1999; Huppert el al., 2001; Loeb et al., 2005; Webb, DeRubeis, & Barber, 2010) 
and imply that in and of itself, strict adherence to a treatment approach does not predict symptomatic change 
(Shaw et al., 1999).  
Adherence – outcome relationships differed, however, across treatment conditions and revealed several 
disadvantages for high levels of therapist adherence. If replicated, increasing general anxiety symptoms are 
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associated with highly adherent instructing, preparing and rehearsing exposure in completers doing the exposure 
in situ by themselves (T-). In dropouts who were accompanied during the exposure by the therapists (T+) more 
agoraphobic avoidance was associated with a strict treatment approach too. Because T+ was more structured 
than T-, results suggest that a too strict adherence in a thoroughly standardized treatment might be detrimental 
for dropouts but not for completers. However, based on small effects and no significant interactions between 
group and adherence, these conclusions remain speculative.  
Surprisingly, neither competence nor experience influenced the relationship between treatment outcome and 
adherence. One explanation for these findings might be that therapists in the present study were carefully trained 
to an acceptable standard of competent behaviour independently of their experience. Moreover, results might be 
biased by a restricted range of experience. About 60% of therapists reported no more than three years of 
experience. In this regard, it might be possible that (a) therapists’ prior practical experience was sufficient for 
delivering treatment as intended to achieve symptomatic improvement, (b) the effect of adherence on 
symptomatic change was independent of therapist experience, or (c) the number of years of experience was not 
an adequate operational definition of experience but rather experience with specific cases. And finally, many 
unmeasured variables may influence the association between adherence and outcome in ways that are not 
necessarily controllable for the therapist, such as the time of symptom change (Webb, DeRubeis, & Barber, 
2010). For instance, symptomatic improvement during the treatment could be an indicator for some therapists to 
strictly implement the manual as intended (Loeb et al., 2005) whereas other therapists initiate a more flexible 
treatment approach (Gresham, MacMillan, Beebe-Frankenberger, & Bocian, 2000; Webb, DeRubeis, & Barber, 
2010).  
Because a more flexible treatment approach was found to be somewhat more advantageous in the present 
study, an important practical implication for the therapeutic practice might be to use a treatment manual rather as 
a guideline than as an inflexible script (Kendall & Beidas, 2007; Kendall, Gosch, Furr, & Sood, 2008). 
Therapists, especially those who implement exposure-related CBT, should be able to adapt proved strategies to 
the present situation without deviating from salient therapeutic principles and agreed-upon therapy goals. 
Another useful suggestion might be to clarify the reasons and consequences of non-adherent behaviour for a 
better understanding of the processes that lead to change by using process measures. Questionnaires should be 
completed by patient and therapist measuring issues such as the perceived change over the course of therapy, the 
attributation of those changes to, the helpfulness of aspects of treatment, the therapeutic relationship as well as 
current understanding problems and patient motivation. The outcome of this procedure might not only inform 
about situational and individual patient characteristics moderating the relationship between adherence and 
outcome (Huppert, Barlow, Gorman, Shear & Woods, 2006) but also about the required level of therapist 
adherence in the next therapy session. Analysing this information under supervision might help to provide an 
adequate matching of patient’s requirements and the level of therapist adherence.  
4.4 Limitations 
The results of this study should be interpreted in the context of six main limitations. Because exposures in 
situ sessions were implemented outside the therapy room, results are limited to those aspects that were 
videotaped (i.e., prior to leaving and after returning to the therapy room in the T+ condition vs. the entire 
preparation and rehearsal in the T- condition). Second, these data were characterized by low variability in 
adherence ratings. Nearly 80% of sessions were rated between “moderately” and “highly” adherent. As a result, 
our ability to detect otherwise meaningful patterns may have been restricted by the reduced variance in 
adherence. This study is further limited by the use of observer ratings of adherence. Different results may be 
possible if the therapist rated adherence. Moreover, the relatively small number of patients in some of the 
subgroup analyses of dropouts may have limited statistical power. Because the study was neither designed nor 
powered to answer these complex and multifaceted questions our results must interpreted with caution. 
Additionally, LOCF analyses can only reflect therapeutic processes up to the point of dropout and not beyond. 
Finally, our results are limited to patients with PD/AG who participate in outpatient mental health services at 
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psychology and psychiatry departments of research universities. 
5. Conclusion 
The results of the present study add to the small but growing literature suggesting that therapist adherence 
does not directly predict treatment outcome in general. However, considering treatment characteristics we 
observed some evidence for a link between lower level of therapist adherence and symptomatic improvement. 
Moreover, our results of adherence scores across patients who dropped out due to exposure related reasons 
proposed that further studies should concentrate on therapist and patient characteristics associated with therapist 
adherence. The challenge for future research will be to identify the relative impact of adherence and other 
therapist variables on treatment outcome for understanding the mechanisms of change in CBT for patients with 
PD/AG.  
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